Respiratory
Respiratory infections are one of the leading causes of death worldwide
According to the World Health Organization (WHO), infections of respiratory system are responsible for an estimated 4 million deaths each year, with majority of these deaths occurring in low- and middle-income countries. The elderly, young children, and individuals with underlying health conditions and immunocompromised patients (such as ones with pulmonary/lung diseases, cancer and organ transplant) are particularly at risk for severe respiratory infections. These infections can be caused by various pathogens, including viruses, bacteria, and fungi, and can range from mild to severe. Some common types of respiratory infections include the common cold, influenza, pneumonia, bronchitis, and tuberculosis.
Bruker’s PCR-based molecular diagnostic methods offer a great degree of accurate early diagnosis and support early containment as well as management of respiratory infections. LiquidArray® multiplex PCR system is a powerful tool for detecting multiple pathogens at the same time. Additionally, Bruker’s FluoroType® molecular diagnostic tests provide rapid, easy-to-use solutions which are crucial for patient care and for controlling the spread of the infection.
Bruker offers a wide range of diagnostic solutions to help quickly and accurately identify the pathogens causing respiratory diseases.
